Stanford University School of Medicine
Stanford, CA
Marina Francis, PhD
Stanford University School of Medicine, Stanford, CA, United States
Dr. Francis is a Postdoctoral Scholar who recently joined Dr. Everett Moding’s lab at the Department of Radiation Oncology at Stanford University School of Medicine. She is using genomic analysis of patient samples and preclinical models to identify new targets that sensitize sarcoma to treatments like radiation and immunotherapy. Before joining Stanford University, she completed her PhD in Biomedical Sciences at the American University of Beirut, where she worked in Dr. Youssef Zeidan’s lab investigating the role of the sphingolipid-modifying enzyme SMPDL3b in radiation nephropathy. Her research interests revolve around improving cancer treatment outcomes and patients’ quality of life by optimizing radiation therapy, combined treatment strategies, and personalized precision oncology.
Disclosures:
2790 - Novel Role for SMPDL3b in Radiation Nephropathy
Monday, September 30, 2024
5:00 PM – 6:00 PM ET